To study the sensitivity and specificity of NGS in detecting Microsatellite State in blood and to evaluate its potential application in gastrointestinal cancer.
To investigate treatment-specific mutations that underlie resistance to treatment with chemotherapy +/- bevacizumab or cetuximab in first line metastatic Colorectal Cancer (mCRC) patients, we performe
The study goal is to evaluate genetic heterogeneity of circulating tumor cells (CTC) isolated from the blood of patients with metastatic breast cancer. Single CTCs were isolated using EpCAM-independen
